SK Chemicals of Korea has signed a deal with AstraZeneca to manufacture diabetes drug Sidapvia through the rest of the decade, according to a regulatory filing.
SKYCovion, the Covid-19 vaccine developed by SK Chemicals, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).
EMA’s human medicines committee (CHMP) has started a review of a conditional marketing authorisation application for Skycovion, a vaccine for protecting against COVID-19.
Standigm Inc, an artificial intelligence (AI)-based drug discovery company and SK Chemicals Co, Ltd, a life science and green chemicals company, both based in South Korea, have announced that they have successfully found a new rheumatoid arthritis indication for an FDA-approved drug and have filed a patent. This is the first successful result of their open innovation partnership, formed in July 2019.